Operose Advisors »

Peregrine Pharmaceuticals shares owned by Operose Advisors

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Operose Advisors from 13F filings

Historical chart of Operose Advisors investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Operose Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Operose Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $13k 2.0k 6.50
2023-09-30 $7.3k 775 9.44

More positions owned by Operose Advisors

Vanguard High Dividend Yield ETF Etf (VYM)
Vanguard Total Stock Market ETF Etf (VTI)
iShares Core S&P Small-Cap ETF Etf (IJR)
Vanguard FTSE Developed Markets ETF Etf (VEA)
Vanguard Mid-Cap Growth ETF Etf (VOT)
iShares International Select Dividend ETF Etf (IDV)
Schwab International Equity ETF Etf (SCHF)
Spdr S&p 500 Etf Etf (SPY)
Vanguard FTSE All-World ex-US Sm-Cp ETF Etf (VSS)
iShares S&P Small-Cap 600 Value ETF Etf (IJS)
iShares Russell 2000 ETF Etf (IWM)
Artisan Partners Asset Management Common (APAM)
iShares Select Dividend ETF Etf (DVY)
Microsoft Corp Common (MSFT)
iShares Core S&P 500 ETF Etf (IVV)

View all positions for Operose Advisors

Top funds holding Peregrine Pharmaceuticals

Millennium Management
Vanguard Group
AltraVue Capital
Royal Bank of Canada
Palisade Capital Management
Wellington Management Company
Punch & Associates Investment Management
AWM Investment Company
Kornitzer Capital Management
New York State Common Retirement Fund
Dimensional Fund Advisors
Sargent Investment Group
Goldman Sachs Group
B. Riley Asset Management
Two Sigma Investments

View all funds holding Peregrine Pharmaceuticals